Procter & Gamble Health Limited — Important, 29-05-2025: General Updates

Procter & Gamble Health reported revenue growth to ₹934.17 Cr and pre-tax profit rising to ₹311.62 Cr for the nine months ended March 31, 2025. Net profit stood at ₹234.41 Cr. The company has shifted to contract manufacturing for injections after closing its Goa plant. A final dividend of ₹45 per share has been proposed, subject to shareholder approval. The audit report was clean, reflecting solid operational and financial stability.